A detailed history of Deka Bank Deutsche Girozentrale transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 23,022 shares of ANIP stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,022
Previous 23,022 -0.0%
Holding current value
$1.34 Million
Previous $1.44 Million 8.32%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$50.28 - $64.61 $151,946 - $195,251
3,022 Added 15.11%
23,022 $1.34 Million
Q2 2023

Jul 25, 2023

BUY
$37.29 - $53.83 $372,900 - $538,300
10,000 Added 100.0%
20,000 $1.06 Million
Q4 2022

Feb 01, 2023

BUY
$31.9 - $41.95 $319,000 - $419,500
10,000 New
10,000 $408,000
Q4 2021

Feb 02, 2022

SELL
$32.97 - $56.85 $113,746 - $196,132
-3,450 Closed
0 $0
Q3 2020

Oct 29, 2020

BUY
$26.38 - $33.1 $91,011 - $114,195
3,450 New
3,450 $96,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.01B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.